Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML

Leukemia

Volumn 10, Issue 3, 1996, Pages 426-433

  Beck, J ^a   Handgretinger, R ^a   Klingebiel, T ^a   Dopfer, R ^a   Schaich, M ^a   Ehninger, G ^a   Niethammer, D ^a   Gekeler, V ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b ALTANA PHARMA AG   (Germany)

Author keywords

Acute myelogeneous leukemia; Glutathione S transferase ; MDR1 P glycoprotein; MRP; Multidrug resistance; PKC isozymes

Indexed keywords

COMPLEMENTARY DNA; CYCLIN A; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); GLUTATHIONE TRANSFERASE; ISOENZYME; MESSENGER RNA; PROTEIN KINASE C;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MULTIDRUG RESISTANCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

EID: 0029964052     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Endicott JA, Ling V. The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 1989; 58: 137-171.
2. Gottesman MM, Schoenlein PV, Currier SJ, Bruggemann EP, Pastan I. Biochemical basis for multidrug resistance in cancer. Biochem Mol Aspects Sel Cancers 1991; 1: 339-371.
3. Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992; 258: 1650-1654.
4. Grant C, Valdimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG. Overexpression of rnultidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 1994; 54: 357-361.
5. Pommier Y, Kerrigan D, Schwartz RE, Swack JA, McCurdy A. Altered DNA topoisomerase II activity in chinese hamster cells resistant to topoisomerase inhibitors. Cancer Res 1986; 46: 3075-3081.
6. Chung TD, Drake FH, Tan KB, Per SR, Crooke ST, Mirabelli CK. Characterization and immunological identification of cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci USA 1989; 86: 9431-9435.
7. Fernandes DJ, Danks MK, Beck WT. Decreased nuclear matrix DNA topoisomerase II in human leukemia cells resistant to VM-26 and m-AMSA. Biochemistry 1990; 29: 4235-4241
8. DeJong S, Zijlstra JG, de Vries EGE, Mulder NH. Reduced DNA topoisomerase II activity and drug-induced DNA cleavage activity in an adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res 1990; 50: 304-309.
9. Beck WT, Danks MK, Wolverton JS, Kim R, Chen M. Drug resistance associated with altered topoisomerase II Adv Enzyme Regul 1993; 33: 113-127.
10. Mirski SEL, Evans CD, Almquist KC, Slovak ML, Cole SPC. Altered topoisomerase IIα in a drug-resistant small cell lung cancer cell line selected in VP-16. Cancer Res 1993; 53: 4866-4873.
11. Schneider E, Horton JK, Yang CH, Nakagawa M, Cowan KH. Multidrug resistance-associated protein gene overexpression and reduced drug sensitivity of topoisomerase II in a human breast carcinoma MCF7 cell line selected for etoposide resistance. Cancer Res 1994; 54: 152-158.
12. Brown GA, McPherson JP, Gu L, Hedley DW, Toso R, Deuchars KL, Freedman MH, Goldenberg GJ. Relationship of DNA topoisomerase IIα and β expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. Cancer Res 1995; 55: 78-82.
13. Ma DDF, Davey RA, Harman DH, Isbister JP, Scurr RD, Mackertich SM, Dowden G, Bell DR. Detection of a multidrug resistant phenotype in acute nonlymphoblastic leukaemia. Lancet 1987; 17: 135-137.
14. Rothenberg ML, Mickley LA, Cole DE, Balis FM, Tsuruo T, Poplack DG, Fojo AT. Expression of the mdr-1/P-170 gene in patients with acute lymphoblastic leukemia. Blood 1989; 74: 1388-1395.
15. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I. Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 1989; 81: 116-124.
16. Niethammer D, Diddens H, Gekeler V, Frese G, Handgretinger R, Henze G, Schmidt H, Probst H. Resistance to methotrexate and multidrug resistance in childhood malignancies. Adv Enzyme Regul 1989; 29: 231-245.
17. Kuwazuru Y, Yoshimura A, Hanada S, Utsunomiya A, Makino T, Ishibashi K, Kodama M, Iwahashi M, Arima T, Akiyama S. Expression of the multidrug transporter, P-glycoprotein, in acute leukemia cells and correlation to clinical drug resistance. Cancer 1990; 66: 868-873.
18. Herweijer H, Sonneveld P, Baas F, Nooter K. Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine. J Natl Cancer Inst 1990; 82: 1133-1140.
19. Marie JP, Zittoun R, Sikic BI. Multidrug resistance (mdr1) gene expression in adult acute leukemias: correlations with treatment outcome and in vitro drug sensitivity. Blood 1991; 78: 586-592.
20. Gekeler V, Frese G, Noller A, Handgretinger R, Wilisch A, Schmidt H, Muller C, Dopfer R, Klingebiel T, Diddens H, Probst H, Niethammer D. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase π gene expression in primary and relapsed state adult and childhood leukaemias. Br J Cancer 1992; 66: 507-517.
21. Goasguen JE, Dossot J-M, Fardel O, Mee FL, Gall EL, Leblay R, LePrise PY, Chaperon J, Fauchet R. Expression of the multidrug resistance associated P-glycoprotein in 59 cases of de novo acute lymphoblastic leukemia: prognostic implications. Blood 1993; 81: 2394-2398.
22. Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D, Gekeler V. Expression of mdr1, mrp, topoisomerase IIα/β and cyclin A in primary or relapsed states of acute lymphoblastic leukemias. Br J Haematol 1995; 89: 356-363.
23. Mattern J, Volm M. Multiple pathway drug resistance (review). Int J Oncol 1993; 2: 557-561.
24. Gekeler V, Beck J, Noller A, Wilisch A, Frese G, Neumann M, Handgretinger R, Ehninger G, Probst H, Niethammer D. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias. Ann Hematol 1994; 69: S19-S24.
25. Beck J, Niethammer D, Gekeler V High mdr1- and mrp-, but low topoisomerase IIα-gene expression in B-cell chronic lymphocytic leukaemias. Cancer Lett 1994; 86: 135-142.
26. Burger H, Nooter K, Zaman GJ, Sonneveld P, van Wingerden KE, Oostrum RG, Stoter G. Expression of the multidrug resistance-associated protein (mrp) in acute and chronic leukemias. Leukemia 1994; 8: 990-997.
27. Hart SM, Ganeshaguru K, Hoffbrand AV, Prentice HG, Mehta AB. Expression of the multidrug resistance associated protein (MRP) in acute leukemia. Leukemia 1994; 8: 2163-2168.
28. Zhou DC, Hoang NL, Delmer A, Faussat AM, Russo D, Zittoun R, Marie JP. Expression of resistance genes in acute leukemia. Leuk Lymphoma 1994; 1:27-30.
29. Schneider E, Cowan KH, Bader H, Toomey S, Schwartz GN, Karp JE, Burke PJ, Kaufmann SH. Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 1995; 85: 186-193.
30. Schuurhuis GJ, Broxterman HJ, Ossenkoppele GJ, Baak JPA, Eekman CA, Kuiper CM, Feller N, van Heijningen THM, Klumper E, Pieters R, Lankelma J, Pinedo HM. Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-β-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemia. Clin Cancer Res 1995; 1: 81-93.
31. Hug H, Sarre TF. Protein kinase C isoenzymes: divergence in signal transduction? Biochem J 1993; 291: 291-343.
32. Grunicke H, Hofmann J, Utz I, Überall F. Role of protein kinases in antitumor drug resistance. Ann Hematol 1994; 69: S1-S6.
33. Goodnight J, Mischak H, Kolch W, Mushinski JF. Immunocytochemical localisation of eight protein kinase C isozymes over-expressed in NIH 3T3 fibroblasts. J Biol Chem 1995; 270: 9991-10001.
34. Mischak H, Pierce JH, Goodnight J, Kazanietz MG, Blumberg PM, Mushinski JF. Phorbol ester-induced myeloid differentiation is mediated by protein kinase C-α and -δ and not by protein kinase C-βII, -ε, -ζ, and -η. J Biol Chem 1993; 268: 20110-20115
35. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Cowan KH, Glazer RI. Transfection with protein kinase Cα confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun 1991; 3. 181-189.
36. Blobe GC, Sachs CW, Khan WA, Fabbro D, Stabel S, Wetsel WC, Obeid LM, Fine RL, Hannun YA. Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKCα. J Biol Chem 1993; 268: 658-664.
37. Gekeler V, Frese G, Diddens H, Probst H. Expression of a P-glycoprotein gene is inducible in a multidrug-resistant human leukemia cell line. Biochem Biophys Res Commun 1988; 155: 754-760.
38. Chaudhary PM, Roninson IB. Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 1993; 85: 632-639.
39. Chambers TC, Pohl J, Raynor RL, Kuo JF. Identification of specific sites in human P-glycoprotein phosphorylated by protein kinase. J Biol Chem 1993; 268: 4592-4595.
40. r 190 000 multidrug resistance protein (MRP) in drug-selected and transfected human tumor cells Cancer Res 1995; 55: 102-110.
41. Sahyoun N, Wolf M, Besterman J, Hsieh T, Sander M, LeVine H III, Chang K, Cuatrecasas P. Protein kinase C phosphorylates topoisomerase II: topoisomerase activation and its possible role in phorbol ester-induced differentiation of HL-60 cells. Proc Natl Acad Sci USA 1986; 83: 1603-1607.
42. Corbett AH, Fernald AW, Osheroff N. Protein kinase C modulates the catalytic activity of topoisomerase II by enhancing the rate of ATP hydrolysis: evidence for a common mechanism of regulation by phosphorylation. Biochemistry 1993; 32: 2090-2097.
43. Gekeler V, Boer R, Ise W, Sanders KH, Schächtele C, Beck J. The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Commun 1995; 206: 119-126.
44. D'Arpa P, Machlin PS, Ratrie H, Rothfield NF, Cleveland DW, Earnshaw WC. cDNA cloning of human DNA topoisomerase I: catalytic activity of a 67.7-kDa carboxyl-terminal fragment. Proc Natl Acad Sci USA 1988; 85. 2543-2547.
45. Kano T, Sakai M, Muramatsu M. Structure and expression of a human class pi glutathione-S-transferase messenger RNA. Cancer Res 1987; 47: 5626-5631.
46. Finkenzeller G, Marmé D, Hug H. Sequence of human protein kinase Cα. Nucleic Acids Res 1990; 18: 2183.
47. Kubo K, Ohno S, Suzuki K. Primary structures of human protein kinase C βI and βII differ only in their C-terminal sequences. FEBS Lett 1987; 223: 138-142.
48. Basta P, Strickland MB, Holmes W, Loomis CR, Ballas LM, Burns DJ. Sequence and expression of human protein kinase Cε. Biochem Biophys Acta 1992; 1132: 154-160.
49. Bacher N, Zisman Y, Berent E, Livneh E. Isolation and characterization of PKC-L, a new member of the protein kinase C-related gene family specifically expressed in lung, skin, and heart. Mol Cell Biol 1991; 11: 126-133.
50. Baier C, Telford D, Giampa L, Coggeshall KM, Baier-Bitterlich G, Isakov N, Altman A. Molecular cloning and characterization of PKCθ, a novel member of the protein kinase C (PKC) gene family expressed predominantly in hematopoietic cells. J Biol Chem 1993; 268: 4997-5004.
51. Ludescher C, Hilbe W, Eisterer W, Preuss E, Huber C, Gotwald M, Hofmann J, Thaler J. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay. J Natl Cancer Inst 1993; 85: 1751-1758
52. Brophy NA, Marie JP, Rojas VA, Warnke RA, McFall PJ, Smith SD, Sikic BI. Mdr 1 gene expression in childhood acute lymphoblastic leukemias and lymphomas: a critical evaluation by four techniques. Leukemia 1994; 8: 327-335.
53. Mischak H, Kolch W, Goodnight J, Davidson WF, Rapp U, Rose-John S, Mushinski JF. Expression of protein kinase C genes in hemopoietic cells is cell-type and B cell-differentiation stage specific. J Immunol 1991; 147: 3981-3987.
54. Roller E, Klumpp B, Krause J, Eichelbaum M, Schumacher K. Influence of sequential exposure to R-verapamil or B8509-035 on rhodamine 123 accumulation in human lymphoblastoid cell lines. Cancer Chem Pharmacol 1993; 32: 151-155.
55. Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ. Topoisomerase II levels and drug sensitivity in adult acute myelogenous leukemia. Blood 1994; 83: 517-530.
56. Van der Zee AGJ, de Jong S, Keith WN, Hollema H, Boonstra H, de Vries EGE. Quantitative and qualitative aspects of topoisomerase I and IIα and β in untreated and platinum/cyclophosphamide treated malignant ovarian tumors. Cancer Res 1994; 54: 749-755.
57. Batist G, Tulpule A, Sinha BK, Katki AG, Meyers CE, Cowan KH. Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 1986; 261: 15544-15449.
58. Greif H, Ben-Chaim J, Shimon T, Bechor E, Eldar H, Livneh E. The protein kinase C-related PKC-L(η) gene product is localized in the cell nucleus. Mol Cell Biol 1992; 12: 1304-1311.